© 2026 Optics and Photonics at Nottingham
43%
56.3%
8.8%
£5m+
Data for 2020-2025 from SciVal
McCrorie, Phoebe; Vasey, Catherine E; Smith, Stuart J; Marlow, Maria; Alexander, Cameron; Rahman, Ruman
Biomedical engineering approaches to enhance therapeutic delivery for malignant glioma Journal Article
In: J. Control. Release, vol. 328, pp. 917–931, 2020.
Abstract | Tags: blood-brain-barrier, brain tumour, Drug delivery, nanoparticles, Polymers, Receptor-targeting
@article{McCrorie2020-ag,
title = {Biomedical engineering approaches to enhance therapeutic
delivery for malignant glioma},
author = {Phoebe McCrorie and Catherine E Vasey and Stuart J Smith and Maria Marlow and Cameron Alexander and Ruman Rahman},
year = {2020},
date = {2020-12-01},
journal = {J. Control. Release},
volume = {328},
pages = {917\textendash931},
publisher = {Elsevier BV},
abstract = {We review the challenges of next-generation therapeutics for
both systemic and localised delivery to brain tumours and
discuss how recent engineering advances may be used to enhance
brain penetration of systemic delivery therapies. The unmet
clinical need which drug delivery seeks to address is discussed
with reference to the therapy obstacles that the intra-tumour
heterogeneity of glioma present. The unmet chemistry and
biomedical engineering challenge to develop controlled release
therapeutics is appraised, with commentary on current
success/failures in systemic carrier-mediated delivery,
including receptor-targeted, cell-based, blood-brain-barrier
disrupting and MRI-guided focused ultrasound. Localised
therapeutic delivery is a relatively under-studied research
avenue and is discussed with reference to existing technologies
in preclinical development. These include convection-enhanced
delivery, alternative catheter delivery, and neuro-surgically
applied delivery systems such as polymeric hydrogels and
interstitial spray. A myriad of nano-scale therapeutic delivery
systems is emerging as potential future medicines for malignant
brain tumours. Such biomedically-engineered systems will
increasingly feature in next-generation neuro-oncological
clinical trials to deliver repurposed and experimental
therapeutics, aimed at achieving therapeutic drug concentrations
in the brain, with associated mortality and morbidity benefits
for patients.},
keywords = {blood-brain-barrier, brain tumour, Drug delivery, nanoparticles, Polymers, Receptor-targeting},
pubstate = {published},
tppubtype = {article}
}
A part of the University of Nottingham
© 2026 Optics and Photonics at Nottingham. Created for free using WordPress and Kubio